Psychosis and Dopamine Pathways - pediagenosis
Article Update

Monday, June 14, 2021

Psychosis and Dopamine Pathways

Psychosis and Dopamine Pathways

Psychosis and Dopamine Pathways

Psychoses are psychogenic mental disorders involving a loss of contact with reality. The most common is schizophrenia, in which perception, thinking, communication, social functioning, and attention are altered. Caused by genetic and environmental factors, it affects approximately 10% of the population. Symptoms are called positive (eg, delusions, hallucinations) or negative (eg, flat affect, apathy); cognitive dysfunction may occur.

Interest in dopamine, 5­HT, and Glu neurotransmitters led to most early drugs’ targeting the dopamine system, primarily as dopamine D2 receptor antagonists. Typical antipsychotics (eg, chlorpromazine, haloperidol) are better for treating positive signs than negative signs. For treating negative signs, the newer (atypical) antipsychotic drugs (eg, clozapine, risperidone) target other receptors, particularly 5­HT. Neurologic (eg, dystonia, parkinsonism), anticholinergic (eg, blurred vision), and antiadrenergic (eg, hypotension) adverse effects can occur.

Share with your friends

Give us your opinion

Note: Only a member of this blog may post a comment.

This is just an example, you can fill it later with your own note.